Vector Blog

Shunt-flushing device for hydrocephalus gets FDA clearance; could help patients avoid extra surgery

Children with hydrocephalus often have shunts implanted to drain the excess cerebrospinal fluid that builds up inside their brain. Unfortunately, shunts have a tendency to plug up. This potentially life-threatening event necessitates emergency surgery to correct or replace the shunt. “If you have a shunt, you are always worried about what might happen in the...

The post Shunt-flushing device for hydrocephalus gets FDA clearance; could help patients avoid extra surgery appeared first on Vector.

Pre-treated blood stem cells reverse type 1 diabetes in mice

Type 1 diabetes is caused by an immune attack on the pancreatic beta cells that produce insulin. To curb the attack, some researchers have tried rebooting patients’ immune systems with an autologous bone-marrow transplant, infusing them with their own blood stem cells. But this method has had only partial success. New research in today’s Science...

The post Pre-treated blood stem cells reverse type 1 diabetes in mice appeared first on Vector.

Who We are

The mission of the Technology and Innovation Development Office (TIDO) to maximize the impact of Boston Children’s innovations on patient health while enhancing the research endeavor.

News and Events

Upcoming Event: Advancing the Development of Neurological Therapies

Join us on November 28th to learn more about Boston Children’s research in neuroscience, and to discuss how to advance new therapies through powerful industry/academic collaborations.

TIDO is proud to announce the release of our new Inventor’s Guide. The booklet details the commercialization process at Boston Children’s, how to work with TIDO to give your invention the best possibility for success, and answers to frequently asked questions we encounter.

@ChildrensTIDO on Twitter

Connect with us

youtube

Terms and Conditions children's hospital
Site Designed and Developed by Genuine